Pluristem Therapeutics Announces FDA Orphan Drug Designation for PLX cell therapy for the Treatment of Graft ... https://t.co/sZpJHaycev
— Marisa Peer (@PeerMarisa) September 25, 2018
from Twitter https://twitter.com/PeerMarisa
September 24, 2018 at 11:37PM
No comments:
Post a Comment